National Status: Improving
Most Recent Data:
55.7
percent
(2023)
National Target:
66.4
percent 1
Desired Direction:
Increase desired
National Baseline:
48.5 percent of Medicare beneficiaries with diabetes mellitus had urinary albumin testing in 2016 2
View CI in the chart by hovering over a data point.
View SE in the chart by hovering over a data point.
Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Total |
48.5 CI 48.3 / 48.6 SE 0.090 |
49.7 CI 49.5 / 49.9 SE 0.090 |
50.4 CI 50.2 / 50.5 SE 0.091 |
51.1 CI 51.0 / 51.3 SE 0.091 |
49.9 CI 49.7 / 50.1 SE 0.094 |
51.9 CI 51.7 / 52.1 SE 0.094 |
52.7 CI 52.5 / 52.9 SE 0.095 |
55.7 CI 55.5 / 55.9 SE 0.096 |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Sex, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Male |
49.4 CI 49.1 / 49.6 SE 0.131 |
50.7 CI 50.4 / 50.9 SE 0.131 |
51.4 CI 51.1 / 51.7 SE 0.131 |
52.1 CI 51.8 / 52.3 SE 0.131 |
51.0 CI 50.8 / 51.3 SE 0.135 |
52.8 CI 52.5 / 53.0 SE 0.135 |
53.7 CI 53.4 / 54.0 SE 0.136 |
56.7 CI 56.4 / 57.0 SE 0.137 |
Female |
47.7 CI 47.4 / 47.9 SE 0.124 |
48.8 CI 48.6 / 49.1 SE 0.124 |
49.4 CI 49.2 / 49.7 SE 0.125 |
50.3 CI 50.0 / 50.5 SE 0.126 |
48.8 CI 48.6 / 49.1 SE 0.130 |
51.1 CI 50.9 / 51.4 SE 0.132 |
51.7 CI 51.5 / 52.0 SE 0.133 |
54.7 CI 54.5 / 55.0 SE 0.135 |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Race/Ethnicity, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
American Indian or Alaska Native |
30.5 CI 28.5 / 32.5 SE 1.012 |
31.5 CI 29.6 / 33.5 SE 0.996 |
31.4 CI 29.4 / 33.3 SE 0.980 |
29.7 CI 27.8 / 31.6 SE 0.969 |
30.5 CI 28.5 / 32.5 SE 1.028 |
29.1 CI 27.1 / 31.2 SE 1.043 |
28.4 CI 26.3 / 30.6 SE 1.102 |
29.7 CI 27.5 / 32.0 SE 1.146 |
Asian |
53.1 CI 52.0 / 54.2 SE 0.558 |
53.3 CI 52.2 / 54.3 SE 0.546 |
56.3 CI 55.2 / 57.3 SE 0.537 |
57.0 CI 55.9 / 58.0 SE 0.528 |
54.6 CI 53.5 / 55.7 SE 0.548 |
58.2 CI 57.1 / 59.2 SE 0.534 |
58.8 CI 57.8 / 59.9 SE 0.531 |
60.8 CI 59.8 / 61.8 SE 0.530 |
Black or African American |
46.0 CI 45.5 / 46.5 SE 0.272 |
47.4 CI 46.8 / 47.9 SE 0.275 |
47.6 CI 47.1 / 48.2 SE 0.280 |
48.9 CI 48.4 / 49.5 SE 0.283 |
47.5 CI 46.9 / 48.1 SE 0.298 |
50.3 CI 49.7 / 50.9 SE 0.308 |
51.8 CI 51.2 / 52.5 SE 0.319 |
54.3 CI 53.6 / 54.9 SE 0.328 |
White |
48.5 CI 48.3 / 48.7 SE 0.100 |
49.7 CI 49.5 / 49.9 SE 0.101 |
50.3 CI 50.1 / 50.5 SE 0.101 |
51.0 CI 50.8 / 51.2 SE 0.101 |
49.8 CI 49.6 / 50.0 SE 0.105 |
51.7 CI 51.5 / 51.9 SE 0.105 |
52.3 CI 52.1 / 52.5 SE 0.106 |
55.5 CI 55.3 / 55.7 SE 0.107 |
Hispanic or Latino |
51.2 CI 50.0 / 52.3 SE 0.603 |
53.1 CI 51.9 / 54.3 SE 0.599 |
53.3 CI 52.1 / 54.4 SE 0.604 |
53.3 CI 52.1 / 54.5 SE 0.608 |
51.1 CI 49.9 / 52.4 SE 0.638 |
53.2 CI 52.0 / 54.5 SE 0.647 |
53.6 CI 52.3 / 54.8 SE 0.660 |
56.5 CI 55.2 / 57.8 SE 0.666 |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Age group, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
65-74 years |
52.6 CI 52.3 / 52.8 SE 0.123 |
53.5 CI 53.3 / 53.7 SE 0.122 |
54.2 CI 54.0 / 54.5 SE 0.123 |
54.8 CI 54.5 / 55.0 SE 0.123 |
53.4 CI 53.2 / 53.7 SE 0.127 |
55.2 CI 55.0 / 55.5 SE 0.128 |
56.2 CI 56.0 / 56.5 SE 0.130 |
59.3 CI 59.0 / 59.6 SE 0.133 |
75-84 years |
47.4 CI 47.1 / 47.7 SE 0.155 |
48.8 CI 48.5 / 49.1 SE 0.156 |
49.5 CI 49.2 / 49.8 SE 0.156 |
50.4 CI 50.1 / 50.7 SE 0.155 |
49.1 CI 48.8 / 49.4 SE 0.160 |
51.3 CI 51.0 / 51.6 SE 0.161 |
51.9 CI 51.5 / 52.2 SE 0.159 |
55.2 CI 54.9 / 55.5 SE 0.158 |
85 years and over |
33.5 CI 33.1 / 34.0 SE 0.242 |
35.3 CI 34.8 / 35.8 SE 0.247 |
35.3 CI 34.8 / 35.8 SE 0.250 |
36.5 CI 36.0 / 37.0 SE 0.254 |
35.4 CI 34.9 / 36.0 SE 0.266 |
38.2 CI 37.6 / 38.7 SE 0.272 |
39.0 CI 38.5 / 39.6 SE 0.274 |
41.5 CI 40.9 / 42.0 SE 0.278 |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Educational attainment, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Educational attainment |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Family income, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Family income |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Geographic location, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Geographic location |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Marital status, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Marital status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Country of birth, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Country of birth |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Veteran status, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Veteran status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Disability status, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Disability status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Sexual orientation, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Sexual orientation |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Gender identity, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
Gender identity |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by High blood pressure status, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
With high blood pressure |
49.3 CI 49.1 / 49.5 SE 0.097 |
50.5 CI 50.3 / 50.7 SE 0.097 |
51.1 CI 50.9 / 51.2 SE 0.097 |
51.8 CI 51.7 / 52.0 SE 0.097 |
50.8 CI 50.6 / 51.0 SE 0.102 |
52.5 CI 52.3 / 52.7 SE 0.102 |
53.4 CI 53.2 / 53.6 SE 0.103 |
56.4 CI 56.2 / 56.6 SE 0.104 |
Without high blood pressure |
43.5 CI 43.0 / 43.9 SE 0.236 |
44.8 CI 44.3 / 45.3 SE 0.240 |
46.0 CI 45.5 / 46.4 SE 0.246 |
46.5 CI 46.0 / 47.0 SE 0.248 |
44.8 CI 44.4 / 45.3 SE 0.240 |
48.2 CI 47.7 / 48.7 SE 0.251 |
48.2 CI 47.7 / 48.7 SE 0.251 |
51.4 CI 50.9 / 51.9 SE 0.258 |
Annual urinary microalbumin measurement among Medicare beneficiaries with diagnosed diabetes by Kidney disease status, 2016-2023
(percent)
Increase desired
| Population | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
With kidney disease |
57.7 CI 57.3 / 58.0 SE 0.175 |
58.6 CI 58.3 / 58.9 SE 0.169 |
59.0 CI 58.7 / 59.3 SE 0.167 |
60.0 CI 59.7 / 60.3 SE 0.162 |
58.9 CI 58.6 / 59.2 SE 0.168 |
61.0 CI 60.7 / 61.4 SE 0.163 |
62.1 CI 61.7 / 62.4 SE 0.161 |
64.8 CI 64.5 / 65.2 SE 0.158 |
Without kidney disease |
45.3 CI 45.1 / 45.5 SE 0.104 |
46.3 CI 46.1 / 46.6 SE 0.105 |
46.9 CI 46.7 / 47.1 SE 0.107 |
47.3 CI 47.1 / 47.5 SE 0.108 |
46.0 CI 45.8 / 46.2 SE 0.112 |
47.7 CI 47.5 / 47.9 SE 0.114 |
48.1 CI 47.9 / 48.3 SE 0.116 |
50.9 CI 50.7 / 51.2 SE 0.119 |